|
|
IPT/IPTLD targets the powerful cell-killing effects of standard chemotherapy on cancer cells, and reduces their destructive side effects on healthy tissues. Insulin Potentiation Therapy for Cancer- Low dose, targeted chemotherapy
|
The diagnosis of cancer invariably brings with it a combination of fear and despair. For most of us, the most dreaded sentence we can hear from a doctor is, “You have cancer”. The weeks and months after this diagnosis bring a whirlwind of medical advice and difficult decisions. Often, there is a recommendation for chemotherapy as a component of treatment.
The theory behind chemotherapy is that a toxic drug will generally have more toxic effects on rapidly dividing cells. Since cancer cells divide rapidly, these drugs should target these cancer cells preferentially. However, many of the body’s normal cells, including those in the gastro-intestinal tract and bone marrow, also divide rapidly. Therefore, these are also vulnerable and damage to these and other cells create “chemotherapy side effects”. Many patients dread chemotherapy and are either reluctant or refuse to try it.
About 40 years ago in Mexico, Dr. Perez Garcia first treated his cancer patients with a new system he developed. He reasoned that if he gave his patients insulin before giving them chemotherapy, he could target the chemo more toward cancer cells using very small doses and spare normal cells. His experience and those of others seemed to confirm this theory and several small studies also supported it. It was shown that cancer cells have 6-15 times the number of insulin receptors as normal cells.
Insulin has other effects as well. In addition to insulin opening up the path (through the cell membrane) for the glucose to enter, it also makes the cell membrane more permeable to other substances including chemotherapy drugs. Thus, because insulin receptors are so concentrated on cancer cells, administering insulin to the cancer patients’ body opens the cancer cell membrane. When this happens, the chemotherapeutic drugs can selectively target the cancer with relatively little effect on the normal cells. Higher concentrations of the chemo drugs will enter the cancer cells in the presence of insulin. A study at George Washington University demonstrated a 10,000 fold increase in intracellular chemotherapy concentration in the presence of insulin. This means a far smaller quantity of chemotherapeutic drugs is needed to achieve the death of cancer cells.
Further, insulin has properties that encourage the cancer cells to enter a phase of DNA synthesis and cell division, when the cell reproduction mechanism is most vulnerable to these chemotherapeutic drugs. Thus, administering insulin provides a double whammy for the cancer. A greater level of chemo drug enters the cancer cells at a time when they are most vulnerable in their life cycle. Another study in Uruguay on breast cancer patients who had developed chemotherapy resistance, showed that insulin given before the chemotherapy could cause a renewed tumor shrinkage response.
Insulin Potentiation Therapy capitalized on these principles. It is not an accepted therapy by conventional oncologists and therefore cannot be considered a substitute for chemotherapy. However, when a patient absolutely refuses chemotherapy but still wants a potentially powerful cancer treatment, he or she may want to consider IPT.
When IPT is combined with diet, supplements, and immune stimulation and other I.V. therapies, the potential benefits can be multiplied.
The preceding is for educational purposes only and is not meant to suggest any specific treatment nor is it meant to imply that we offer all of these treatments. They should not be considered as generally accepted alternatives to conventional medical treatment. All treatment decisions should be made by the patient in the context of trusted medical advice.
